1. Home
  2. TECX vs FPH Comparison

TECX vs FPH Comparison

Compare TECX & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

BUY

Current Price

$35.87

Market Cap

393.0M

Sector

N/A

ML Signal

BUY

Logo Five Point Holdings LLC

FPH

Five Point Holdings LLC

HOLD

Current Price

$5.45

Market Cap

376.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
FPH
Founded
2019
2009
Country
United States
United States
Employees
51
N/A
Industry
Real Estate
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
376.2M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
TECX
FPH
Price
$35.87
$5.45
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$80.40
N/A
AVG Volume (30 Days)
523.8K
176.1K
Earning Date
01-01-0001
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$237,926,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$11.40
Revenue Growth
N/A
12.37
52 Week Low
$13.70
$4.58
52 Week High
$28.98
$6.64

Technical Indicators

Market Signals
Indicator
TECX
FPH
Relative Strength Index (RSI) 82.47 46.72
Support Level $16.83 $5.36
Resistance Level N/A $5.74
Average True Range (ATR) 2.37 0.20
MACD 1.06 0.01
Stochastic Oscillator 97.81 35.63

Price Performance

Historical Comparison
TECX
FPH

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

Share on Social Networks: